Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active pyridine derivatives. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in pharmaceutical research and development, particularly in creating novel drug candidates targeting kinase inhibition and central nervous system disorders. The difluoromethoxy and amino functional groups enhance binding selectivity and metabolic stability in final compounds. Commonly employed in late-stage functionalization during medicinal chemistry optimization.